JSR hands over Crown to Carlyle-backed lab service company in $204M deal
JSR Life Sciences is parting ways with its CRO business Crown Bioscience, selling the unit to a Chinese clinical lab service provider in a deal valued at $204 million (PDF).…
JSR Life Sciences is parting ways with its CRO business Crown Bioscience, selling the unit to a Chinese clinical lab service provider in a deal valued at $204 million (PDF).…